Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

Clinical trial NCT07028970 · RECRUITING

Trial details

NCT number: NCT07028970
Sponsor: Nanjing IASO Biotechnology Co., Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2024-12-15
Primary completion: 2040-12-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.